nach oben

Virchows Archiv

Erschienen in:

01.02.2007 | Letter to the Editor

Expression of epidermal growth factor receptor (EGFR) is frequent in inflammatory bowel disease (IBD)-associated intestinal cancer

verfasst von: Magali Svrcek, Jacques Cosnes, Emmanuel Tiret, Malika Bennis, Yann Parc, Jean-François Fléjou

Erschienen in: Virchows Archiv | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Excerpt

Sir, …

Alexander RJ, Panja A, Kaplan-Liss E, Mayer L, Raicht RF (1995) Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease. Dig Dis Sci 40:485–494PubMedCrossRef

Chung KY, Shia J, Kemeny NE, Shah M, Schwartz GK, Tse A, Hamilton A, Pan D, Schrag D, Schwartz L, Klimstra DS, Fridman D, Kelsen DP, Saltz LB (2005) Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. J Clin Oncol 23:1803–1810PubMedCrossRef

Ciardiello F, Tortora G (2003) Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs. Eur J Cancer 39:1348–1354PubMedCrossRef

Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351:337–345PubMedCrossRef

Goldstein NS, Armin M (2001) Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer stage IV colon adenocarcinoma: implications for a standardized scoring system. Cancer 92:1331–1346PubMedCrossRef

O’Dwyer PJ, Benson AB (2002) Epidermal growth factor receptor-targeted therapy in colorectal cancer. Semin Oncol 29:10–17 (Suppl)PubMedCrossRef

Titel: Expression of epidermal growth factor receptor (EGFR) is frequent in inflammatory bowel disease (IBD)-associated intestinal cancer
verfasst von: Magali Svrcek
Jacques Cosnes
Emmanuel Tiret
Malika Bennis
Yann Parc
Jean-François Fléjou
Publikationsdatum: 01.02.2007
Verlag: Springer-Verlag
Erschienen in: Virchows Archiv / Ausgabe 2/2007
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-006-0338-7

Springer Medizin

Expression of epidermal growth factor receptor (EGFR) is frequent in inflammatory bowel disease (IBD)-associated intestinal cancer

Excerpt

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2007

Expression of E-cadherin and its repressor Snail in placental tissue of normal, preeclamptic and HELLP pregnancies

Primary intravascular myxoid leiomyosarcoma of the femoral vein presenting clinically as deep vein thrombosis: a case report

Sclerosing hemangioma with florid endobronchial and endobronchiolar growth

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma

Renal cell carcinoma with t(X;17)(p11.2;q25) in a 6-year-old Taiwanese boy

Expression of p53/hgf/c-met/STAT3 signal in fetuses with neural tube defects

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie